HomeClinical Trials
Finding and Understanding Clinical Trials
A clinical study examines the effectiveness of new treatments and provides doctors and researchers with data to develop and deliver new, more effective treatments. In a typical year, over one million people participate in clinical studies.
This site provides essential clinical trial information: how medical trials work; your rights as a participant; and learn how signing up for trials can provide access to the best medical facilities and specialists. Participate in a clinical study and you'll help not only yourself, but also the thousands of others who could benefit from the trial's results.
Find a Trial...
You can use this site to find clinical trials by location or by medical condition; see below. Also, by using the search box on the right of this page, you can narrow your search to zip code level.
Current Clinical Trial Listings:
Search results for Leukemia AND Recruiting
1)
Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous LeukemiaLeukemia; Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific
2)
17-N-Allylamino-17-Demethoxygeldanamycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic SyndromesLeukemia; Myelodysplastic Syndromes
3)
Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic LeukemiaLeukemia
4)
Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic LeukemiaChronic Myeloid Leukemia; Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
5)
Phase 1 Study of Terameprocol (EM-1421) in Patients With LeukemiaLeukemias; Acute Myeloid Leukemia (AML); Acute Lymphocytic Leukemia (ALL); Adult T Cell Leukemia (ATL); Chronic Myeloid Leukemia (CML-BP); Chronic Lymphocytic Leukemia (CLL); Myelodysplastic Syndrome (MDS); Chronic Myelomonocytic Leukemia (CMML)
6)
Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic LeukemiaLeukemia
7)
SJG-136 in Treating Patients With Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndromes, Blastic Phase Chronic Myelogenous Leukemia, or Chronic Lymphocytic LeukemiaLeukemia; Myelodysplastic Syndromes
8)
Panobinostat in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid LeukemiaLeukemia
9)
Dasatinib in Imatinib Resistant/Intolerant Chinese CML (Chronic and Accelerated Phase) SubjectsLeukemia
10)
3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous LeukemiaChronic Myeloproliferative Disorders; Leukemia
11)
Bendamustine in Acute Leukemia and MDSAcute Myeloid Leukemia; Myelodysplastic Syndrome; Acute Lymphoblastic Leukemia; Chronic Myeloid Leukemia
12)
Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous LeukemiaLeukemia; Myelodysplastic Syndromes
13)
Azacitidine With or Without MS-275 in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid LeukemiaLeukemia; Myelodysplastic Syndromes
14)
Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid LeukemiaAcute Myeloid Leukemia; Myelodysplastic Syndrome; Chronic Myeloid Leukemia
15)
LMB-2 Immunotoxin in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic LeukemiaLeukemia
16)
Assessment and Determination of Chemotherapy Resistance in Newly-Diagnosed or First Relapse Leukemia PatientsLeukemia
17)
Individualized Exercise Programs for Patients Receiving Chemotherapy for Newly Diagnosed Acute or Relapsed Myeloid Leukemia or Lymphoblastic LeukemiaCancer-Related Problem/Condition; Fatigue; Leukemia
18)
Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia.Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Chronic Lymphocytic Leukemia
19)
Molecular Epidemiology of Childhood Leukemia in Northern and Central CaliforniaLeukemia; Acute Myelocytic Leukemia; Acute Lymphoblastic Leukemia; Acute Myelogenous Leukemia
20)
Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory AnemiaLeukemia; Myelodysplastic Syndromes
